Why the study?
Cardiac remodeling following myocardial infarction is a pathological process, prompting evaluation of the effect of early short-term minocycline on left ventricular function after STEMI treated with primary PCI.
Does early short-term minocycline improve left ventricular function and reduce MMP-9 levels in STEMI patients treated by primary PCI?
Does early short-term minocycline improve left ventricular function and reduce MMP-9 levels in STEMI patients treated by primary PCI?
Early short-term minocycline therapy does not improve cardiac remodeling or reduce MMP-9 levels in patients with STEMI undergoing primary PCI.
Answers are grounded in this paper and cite their sources.
Minocycline does not improve LV remodeling or MMP-9 levels post-STEMI PCI; challenges MMP inhibition as a therapeutic target.
BACKGROUND: Cardiac remodeling following myocardial infarction is a pathological process. We aimed to examine the effect of early short-term minocycline on the left ventricular function following ST-elevation myocardial infarction treated by the primary percutaneous coronary intervention. METHODS: In this double-blind, randomized controlled trial, data of 73 patients STEMI patients who were candidates for primary PCI were enrolled. Patients were then randomized to receive minocycline 50 mg orally, followed by 50 mg once a day for 5 days or a placebo with the same schedule. Measurement of serum matrix metalloproteinase-9 (MMP-9) and 2-dimensional speckle tracking echocardiography was performed at baseline and between 4 and 6 months after discharge. Then the demographic, clinical, echocardiographic, and angiographic data, as well as the levels of MMP-9, were compared between the study groups. RESULTS: There was no statistically significant difference between the study groups regarding the baseline characteristics. Serum levels of MMP-9 did not change following the intervention within each group and were not significantly different between the groups after follow-up. In the follow-up echocardiography, we also did not observe any difference between the two groups CONCLUSION: In this study, we did not observe any effect of minocycline on cardiac remodeling based on 2-dimensional speckle tracking echocardiography and MMP-9 levels. TRIAL REGISTRATION: Iranian Registry of Clinical Trials IRCT201411188698N15 . Registered on 22 June 2015, prospectively.
No takes yet. Share an insight, caveat, or question.
Nasiri et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: